Charles Bonnet syndrome: a review

  title={Charles Bonnet syndrome: a review},
  author={Anita P Schadlu and Ramin Schadlu and James Banks Shepherd},
  journal={Current Opinion in Ophthalmology},
Purpose of review The aging of the population and the resultant increase in the number of patients with low vision due to age-related macular degeneration and other ocular diseases necessitate an increase in awareness of the Charles Bonnet syndrome among ophthalmic care providers. Recent findings The clinical features of Charles Bonnet syndrome have been described by several different authors as formed visual hallucinations due to disturbances of the visual system in patients who are otherwise… 

Charles Bonnet syndrome.

  • O. Stojanov
  • Medicine, Psychology
    Vojnosanitetski pregled
  • 2016
It is essential to distinguish CBS from mental illnesses, since patients with CBS are fully aware that hallucinations are not real, and therefore avoid patients being misdiagnosed.

Seeing the unseen: Charles Bonnet syndrome revisited

Three different ocular morbidities that have been reported to occur in conjunction with CBS are revisited and Psychiatrists and ophthalmologists alike must be sensitive to this clinical condition to ensure prompt diagnosis and treatment.

Charles Bonnet syndrome: characteristics of its visual hallucinations and differential diagnosis.

Physicians who care for low vision patients should be aware of CBS and appropriately diagnose its hallucinations after exclusion of psychiatric and neurologic diseases.

The Prevalence and Characteristics of Charles Bonnet Syndrome in Turkish Patients with Retinal Disease

Investigating the prevalence and clinical characteristics of Charles Bonnet syndrome in a group of Turkish patients with various retinal diseases found that CBS is not uncommon in visually impaired patients with retinal disease, and Clinicians who care for visually impairment patients should be aware of CBS.

Charles Bonnet plus syndrome: apropos of a case

Purpose Charles Bonnet syndrome plus is an exceedingly rare variant of this disorder. The variant has been described in patients with sight impairment and severe hypoacusis, and is usually

The Prevalence and Clinical Characteristics of Charles Bonnet Syndrome in the Republic of Korea

It is found that relatively young patients with visual impairment could experience cVH from CBS, and CBS patients experienced negative emotions for long periods due to the hallucinations which decreased their quality of life.

Charles Bonnet syndrome: characteristics of its visual hallucinations and differential

ABSTRACTObjective: To present an eight-case serie of patients with Charles Bonnet syndrome (CBS). Method: All patients were initially evaluated byan ophthalmologist and then submitted to a neurologic

Atypical Charles Bonnet syndrome secondary to frontal meningioma: a case report

This case aims to present the association of visual hallucinations with complex alterations of the nervous structures adjacent to the visual pathway and an atypical clinical presentation, thus explaining the possible mechanisms involved in the generation of these symptoms.

Charles Bonnet syndrome in cranio-maxillofacial surgery: case report

A 68-year-old male patient underwent an operation to repair a unilateral orbital floor fracture and subsequent eye patching by a Frost suture, and complained of complex, colored visual hallucinations three hours after waking from general anesthesia, which may result in acute onset of visual hallucinations.



Charles Bonnet Syndrome in Age-Related Macular Degeneration: The Nature and Frequency of Images in Subjects with End-Stage Disease

The prevalence of Charles Bonnet syndrome in late AMD is high, the main risk factor being poor better eye visual acuity, and the most commonly experienced hallucinations were of people.

The Charles Bonnet syndrome: a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen.

The findings support association of CBS with sensory deprivation and advanced age and no significant associations with ophthalmic diagnoses, patient sex, marital status, or social circumstances were found.

Dementia with lewy bodies and charles bonnet syndrome.

Ophthalmologists and retina specialists, in particular, should be familiar with the features of dementia with Lewy bodies because the diagnosis of this condition can allow appropriate intervention and help prevent drug-related side effects.

Rehabilitation in Charles Bonnet syndrome: a review of treatment options

A review of the literature highlighted a range of visual, pharmacological and social management regimes that may alleviate visual hallucinations associated with Charles Bonnet syndrome, albeit using small samples in uncontrolled trials.

Charles bonnet syndrome associated with age-related macular degeneration.

Reestablishment of high resolution visual input leads to a dramatic and almost immediate increase in the stimulus threshold of visual cortex cells as reflected by resolution of symptoms.

Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors

This is the first case to show that selective serotonin (and noradrenalin) reuptake inhibitors may be an effective and well-tolerated treatment for visual hallucinations associated with vision loss, and it adds to evidence implicating serotonergic pathways in the pathogenesis of visual hallucinations.

Treatment of typical Charles Bonnet syndrome with donepezil.

The effectiveness of donepezil indicates that the patient's visual hallucinations might be related to dysfunction of cholinergic neurones, although she did not exhibit any cognitive decline, or morphological and physiological brain pathology, and it may be a safer option for the treatment of CBS in the elderly.

Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome).

The extent of visual loss did not appear to be a predictor for the likelihood of a patient with age-related macular degeneration experiencing a CBS VH, nor was the progression of loss reflected in the complexity of the VHs reported.